Keratinocytes and mast cells have been shown to be a major source of vascular endothelial growth factor (VEGF) expression in AD; in fact, VEGF levels are elevated in the serum and skin of patients with AD compared with healthy controls (53–57). Here, VEGFA is linked to Alzheimer disease.